Cashu FinanceCashu Finance
  • Terminal
  • Pulse
  • Spotlight
  • News
  • Cashu Research
Log inSign Up
← Back to Terminal
  1. Stocks
  2. Financial Services
  3. NYSE
  4. UBS

Market Cap: $139.77B

UA

UBS Group AG

UBS
NYSE (New York Stock Exchange)USD
Invest in UBS
OverviewNewsAnalyst ReportsFinancialsPolitician TradesInsider TradesExecutive
Cashu FinanceCashu Finance

By Cashu Finance. Providing market news, analysis, and research for investors worldwide.

Company

StocksScreenersAboutAuthorsAdvertisersBrokersConferencesContact

Legal

Terms of ServicePrivacy PolicyEditorial PolicyCorrections Policy

© 2026 Cashu Technologies Pty Ltd. All rights reserved. Cashu Finance is a trademark of Cashu Technologies Pty Ltd.

The content published on Cashu Finance is for informational purposes only and should not be construed as investment advice, a recommendation, or an offer to buy or sell any securities. All opinions expressed are those of the authors and do not reflect the official position of Cashu Technologies Pty Ltd or its affiliates. Past performance is not indicative of future results. Investing involves risk, including the possible loss of principal. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions.

Cashu Finance and its contributors may hold positions in securities mentioned in published content. Any such holdings will be disclosed at the time of publication. Market data is provided on an "as-is" basis and may be delayed. Cashu Technologies Pty Ltd does not guarantee the accuracy, completeness, or timeliness of any information presented.

Cashu Research is part of Cashu Technology Pty Ltd, which is an authorised representative (AR # 001318029) of Adviser Solutions Group Pty Ltd (ABN 88 601 875 521) (AFSL 485946) (ASG).

This material is general advice only and is not an offer for the purchase or sale of any financial product or service. The material is not intended to provide you with personal financial or tax advice and does not take into account your personal objectives, financial situation or needs. Although we believe that the material is correct, no warranty of accuracy, reliability or completeness is given, except for liability under statute which cannot be excluded. Please note that past performance may not be indicative of future performance and that no guarantee of performance, the return of capital or a particular rate of return is given by Cashu Technologies Pty Ltd, any of their related body corporates or any other person. To the maximum extent possible, Cashu Technologies Pty Ltd, their related body corporates or any other person do not accept any liability for any statement in this material.

UBS Group AG Financials

Profitability, balance-sheet strength and valuation from the latest reported results (trailing twelve months).

Financial Health Scores

Piotroski F-Score

7/9 · Strong

Nine pass/fail checks on profitability, leverage, liquidity and efficiency. 7–9 is strong, 0–3 is weak.

Altman Z-Score

-0.27
Distress <1.8Grey 1.8–3Safe >3

Distress zone: elevated bankruptcy risk.

From Revenue to Profit

How much of each dollar of sales is kept at each stage (last 12 months).

  • Revenue$76.03B100.0%
  • Gross Profit$60.41B79.5%
  • EBITDA$18.39B24.2%
  • Operating Profit (EBIT)$14.39B18.9%
  • Net Profit$11.49B15.1%

Balance Sheet Snapshot

Total assets of $1.71T, funded by:

Liabilities
$1.62T(95%)
Shareholders' equity
$89.43B
Debt / Equity
4.21x
Current Ratio
0.39x

Short-term liabilities exceed short-term assets.

Returns on Capital

How well management turns capital into profit. Above 10–15% is generally considered strong.

  • Return on Equity10.5%

    Profit generated per dollar of shareholders' money.

  • Return on Assets0.6%

    Profit generated per dollar of assets owned.

  • Return on Invested Capital1.5%

    Profit generated on debt and equity invested in the business.

  • Return on Capital Employed2.0%

    Operating profit per dollar of long-term capital.

Valuation at a Glance

Lower multiples can mean cheaper shares, or a market expecting weaker results.

Price / Earnings
15.62x

What investors pay for each dollar of yearly profit.

Price / Book
1.61x

Share price vs net assets per share. Under 1x = below book value.

Price / Sales
2.32x

Market cap vs yearly revenue.

EV / EBITDA
19.18x

Whole-business value (incl. debt) vs operating cash earnings.

Price / Free Cash Flow
n/m: negative free cash flow

Market cap vs cash left after capital spending.

PEG Ratio
0.31x

P/E adjusted for earnings growth. Around 1x is often seen as fair.

All Key Metrics

Every trailing-twelve-month ratio behind the charts above, grouped by topic. Pick a category to browse.

Profitability

How much of each dollar of revenue turns into profit at each stage, over the last 12 months.

Gross Profit Margin
79.46%
EBITDA Margin
24.19%
EBIT Margin
18.92%
Pre-tax Margin
18.92%
Net Profit Margin
15.11%
Earnings Yield
6.22%

Valuation Multiples

How the share price compares with earnings, sales, book value and cash flow. Lower multiples can mean cheaper shares, or weaker prospects.

Price / Book
1.61
Price / Sales
2.32
Price / Earnings
15.62
PEG
0.31
Forward PEG
0.38
EV / Sales
5.27
EV / EBITDA
19.18
EV / Operating Cash Flow
76.62
EV / Free Cash Flow
88.70
Price / Free Cash Flow
-122.66
Price / Operating Cash Flow
-3103.63

Cash Flow & Capital

How much cash the business generates, how much it reinvests, and what it returns to shareholders.

Free Cash Flow / Share
-$0.38
Operating Cash Flow / Share
-$0.01
Free Cash Flow Yield
2.29%
Capex / Revenue
0.94%
Capex / Operating Cash Flow
13.62%
Capex / Depreciation
0.23
Stock Compensation / Revenue
0.00%
Dividend Payout Ratio
0.86%
Dividend Yield
2.22%

Liquidity & Leverage

Whether the company can cover its short-term bills and how heavily it relies on debt.

Current Ratio
0.39
Quick Ratio
0.39
Cash Ratio
0.20
Debt / Assets
0.22
Debt / Capital
0.81
Debt / Equity
4.21
Long-Term Debt / Capital
0.77
Debt / Market Cap
260.28%
Net Debt / EBITDA
9.72
Solvency Ratio
0.01
Financial Leverage
19.15

Efficiency & Working Capital

How quickly the company turns assets, inventory and receivables into sales and cash.

Asset Turnover
0.04
Fixed Asset Turnover
3.84
Inventory Turnover
0.00
Receivables Turnover
1.24
Payables Turnover
0.15
Days Sales Outstanding
270.43
Days Inventory Outstanding
0
Days Payables Outstanding
4,020.38
Operating Cycle
270.43
Cash Conversion Cycle
-3,749.95
Working Capital Turnover
-0.27

Returns & Quality

How efficiently management turns shareholders' money and company assets into profit.

Return on Equity
10.53%
Return on Assets
0.57%
Return on Invested Capital
1.48%
ROCE
1.98%
Return on Tangible Assets
0.58%
Operating Return on Assets
0.74%
Income Quality
0.40
Tax Burden
0.77
Interest Burden
1.00

Balance Sheet & Intrinsic Metrics

What the company owns and owes, and asset-based value estimates per share.

Enterprise Value
$296.25B
Invested Capital
$-611.91B
Working Capital
$-634.18B
Tangible Asset Value
$82.1B
Net Current Asset Value
$-1.17T
Graham Number
$43.46
Graham Net-Net
-$372.96
Book Value / Share
$28.91
Tangible Book Value / Share
$26.7
Cash / Share
$118.83

Financial Health Scores

Composite scores and the latest reported totals behind them.

Piotroski Score
7
Altman Z-Score
-0.27
Revenue
$76.03B
EBIT
$17.87B
Market Cap
$118.34B
Working Capital
$-652.74B
Retained Earnings
$86B
Total Assets
$1.71T
Total Liabilities
$1.62T